AEHR executive sells 5,400 shares in open market
AEHR Test Systems executive Didier Wimmers reported open-market sales of 5,400 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AEHR Test Systems executive Didier Wimmers reported open-market sales of 5,400 shares of common stock. He sold 3,500 shares on April 13, 2026 at an average price of $71.1102 per share and 1,900 shares on April 15, 2026 at an average price of $72.0239.
After these transactions, Wimmers directly holds 10,659 shares of AEHR common stock, and this amount includes shares subject to unvested restricted stock units. All reported transactions were classified as open-market sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,900 | $72.0239 | $137K |
| Sale | Common Stock | 3,500 | $71.1102 | $249K |
Footnotes (1)
- F1. The amount reported includes shares subject to unvested restricted stock units.
Key Figures
Key Terms
open-market sale financial
restricted stock units financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did AEHR EVP of R&D Didier Wimmers report?
On what dates did AEHR’s EVP of R&D sell company stock?
What type of insider transaction is reported in the AEHR Form 4?
Does the AEHR Form 4 mention restricted stock units for Didier Wimmers?
AI-generated analysis. How Rhea-AI works. Not financial advice.